Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
51	51 Vera Therapeutics VERA $1.52B	179% upside 4 price targets	0
52	52 Coya Therapeutics COYA $99.8M	176% upside 4 price targets	0
53	CAN 53 Canaan Creative CAN $439M	175% upside 4 price targets	0
54	54 Arrowhead Research ARWR $2.63B	175% upside 3 price targets	0
55	BCYC 55 Bicycle Therapeutics BCYC $565M	170% upside 7 price targets	0
56	56 Leslie's LESL $75.5M	166% upside 3 price targets	0
57	57 Syndax Pharmaceuticals SNDX $837M	162% upside 4 price targets	0
58	58 Solid Biosciences SLDB $467M	157% upside 8 price targets	0
59	59 Nuvation Bio NUVB $766M	152% upside 3 price targets	0
60	60 EyePoint Pharmaceuticals EYPT $713M	149% upside 4 price targets	0
61	61 W.P. Carey WPC $13.5B	148% upside 4 price targets	0
62	TVRD 62 Tvardi Therapeutics, Inc. Common Stock TVRD $225M	147% upside 5 price targets	0
63	63 Beam Therapeutics BEAM $2.06B	144% upside 3 price targets	0
64	64 ADC Therapeutics ADCT $355M	143% upside 3 price targets	0
65	ADAP 65 Adaptimmune Therapeutics ADAP $73.1M	137% upside 3 price targets	0
66	66 Prairie Operating Co PROP $167M	136% upside 5 price targets	0
67	67 Blink Charging BLNK $99.3M	134% upside 3 price targets	0
68	68 MacroGenics MGNX $99.7M	132% upside 3 price targets	0
69	AIOT 69 PowerFleet, Inc. Common Stock AIOT $599M	130% upside 3 price targets	0
70	70 Nurix Therapeutics NRIX $946M	119% upside 6 price targets	0
71	71 AngioDynamics ANGO $354M	118% upside 3 price targets	0
72	72 CG Oncology CGON $2.15B	117% upside 6 price targets	0
73	73 Castle Biosciences CSTL $507M	113% upside 3 price targets	0
74	74 Weave Communications WEAV $567M	112% upside 3 price targets	0
75	75 AbCellera Biologics ABCL $1.18B	112% upside 3 price targets	0

12345

65